BR9907234A - Polìmeros ligantes de gordura - Google Patents
Polìmeros ligantes de gorduraInfo
- Publication number
- BR9907234A BR9907234A BR9907234-3A BR9907234A BR9907234A BR 9907234 A BR9907234 A BR 9907234A BR 9907234 A BR9907234 A BR 9907234A BR 9907234 A BR9907234 A BR 9907234A
- Authority
- BR
- Brazil
- Prior art keywords
- fat
- binding polymers
- polymers
- binding
- methods
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 6
- 238000000034 method Methods 0.000 abstract 5
- 229940127470 Lipase Inhibitors Drugs 0.000 abstract 1
- SIKWOTFNWURSAY-UHFFFAOYSA-N Lipstatin Natural products CCCCCCC1C(CC(CC=CCC=CCCCCC)C(=O)OC(CC(C)C)NC=O)OC1=O SIKWOTFNWURSAY-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- AHLBNYSZXLDEJQ-UHFFFAOYSA-N N-formyl-L-leucylester Natural products CCCCCCCCCCCC(OC(=O)C(CC(C)C)NC=O)CC1OC(=O)C1CCCCCC AHLBNYSZXLDEJQ-UHFFFAOYSA-N 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 235000013367 dietary fats Nutrition 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000006575 hypertriglyceridemia Diseases 0.000 abstract 1
- OQMAKWGYQLJJIA-CUOOPAIESA-N lipstatin Chemical compound CCCCCC[C@H]1[C@H](C[C@H](C\C=C/C\C=C/CCCCC)OC(=O)[C@H](CC(C)C)NC=O)OC1=O OQMAKWGYQLJJIA-CUOOPAIESA-N 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
- 229960001243 orlistat Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Detergent Compositions (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US496398A | 1998-01-09 | 1998-01-09 | |
| US09/166,453 US6264937B1 (en) | 1998-01-09 | 1998-10-05 | Fat-binding polymers |
| PCT/US1999/000028 WO1999034787A2 (en) | 1998-01-09 | 1999-01-04 | Fat-binding polymers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9907234A true BR9907234A (pt) | 2000-10-10 |
Family
ID=26673719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9907234-3A BR9907234A (pt) | 1998-01-09 | 1999-01-04 | Polìmeros ligantes de gordura |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1043981B1 (enExample) |
| JP (1) | JP2002500183A (enExample) |
| KR (2) | KR20060111741A (enExample) |
| CN (1) | CN1212123C (enExample) |
| AT (1) | ATE237349T1 (enExample) |
| AU (2) | AU740233B2 (enExample) |
| BR (1) | BR9907234A (enExample) |
| CA (1) | CA2318417A1 (enExample) |
| DE (1) | DE69906928T2 (enExample) |
| ES (1) | ES2200493T3 (enExample) |
| HU (1) | HUP0100890A3 (enExample) |
| IL (1) | IL137096A (enExample) |
| MX (1) | MX222446B (enExample) |
| NO (1) | NO20003510L (enExample) |
| NZ (2) | NZ505294A (enExample) |
| PL (1) | PL193452B1 (enExample) |
| RU (1) | RU2222335C2 (enExample) |
| WO (1) | WO1999034787A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6267952B1 (en) * | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
| MXPA02000492A (es) * | 1999-07-14 | 2002-07-02 | Geltex Pharma Inc | Polimeros enlazantes de grasas, opcionalmente combinados con inhibidores de lipasas. |
| EP1219297A4 (en) * | 1999-10-01 | 2004-11-17 | Amato Pharm Prod Ltd | ACTIVE AGENTS AGAINST FATTY ADDICTION |
| KR100572785B1 (ko) | 2000-07-28 | 2006-04-19 | 에프. 호프만-라 로슈 아게 | 신규한 약학 조성물 |
| EP1379259A1 (en) | 2001-04-18 | 2004-01-14 | Genzyme Corporation | Methods of treating syndrome x with aliphatic polyamines |
| US8372430B2 (en) | 2002-12-17 | 2013-02-12 | The Procter & Gamble Company | Compositions, methods, and kits useful for the alleviation of gastrointestinal effects |
| SE0302253D0 (sv) * | 2003-08-21 | 2003-08-21 | Forskarpatent I Syd Ab | Lipase-colipase inhibitor |
| CN106176800B (zh) * | 2016-07-11 | 2019-12-06 | 韩源平 | 多聚阳离子树脂的制药应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7017227A (enExample) * | 1969-12-27 | 1971-06-29 | ||
| US4211765A (en) * | 1971-10-12 | 1980-07-08 | Monsanto Company | Method for controlling obesity |
| US4432968A (en) * | 1980-10-20 | 1984-02-21 | The Dow Chemical Company | Weight control with fat imbibing polymers |
| CA1213397A (en) * | 1980-10-20 | 1986-10-28 | Judith L. Page | Weight control with alkyl styrene polymers |
| EP0354948A1 (fr) * | 1988-02-12 | 1990-02-21 | DE ZAEPFFEL, Brigitte | Copolymere hydrophile reticule a usage medical et paramedical |
| RU2066185C1 (ru) * | 1993-01-11 | 1996-09-10 | Институт пищевых веществ РАН | Гиполипидемический энтеросорбент |
| JP3507523B2 (ja) * | 1993-05-12 | 2004-03-15 | 積水化学工業株式会社 | 糖質吸収抑制剤 |
-
1999
- 1999-01-04 PL PL343898A patent/PL193452B1/pl unknown
- 1999-01-04 ES ES99900369T patent/ES2200493T3/es not_active Expired - Lifetime
- 1999-01-04 KR KR1020067021186A patent/KR20060111741A/ko not_active Ceased
- 1999-01-04 AU AU19505/99A patent/AU740233B2/en not_active Ceased
- 1999-01-04 JP JP2000527238A patent/JP2002500183A/ja active Pending
- 1999-01-04 CA CA002318417A patent/CA2318417A1/en not_active Abandoned
- 1999-01-04 IL IL137096A patent/IL137096A/en active IP Right Grant
- 1999-01-04 DE DE69906928T patent/DE69906928T2/de not_active Expired - Fee Related
- 1999-01-04 HU HU0100890A patent/HUP0100890A3/hu unknown
- 1999-01-04 RU RU2000120918/14A patent/RU2222335C2/ru not_active IP Right Cessation
- 1999-01-04 KR KR1020007007608A patent/KR100773625B1/ko not_active Expired - Fee Related
- 1999-01-04 NZ NZ505294A patent/NZ505294A/xx unknown
- 1999-01-04 BR BR9907234-3A patent/BR9907234A/pt not_active Application Discontinuation
- 1999-01-04 CN CNB998020311A patent/CN1212123C/zh not_active Expired - Fee Related
- 1999-01-04 WO PCT/US1999/000028 patent/WO1999034787A2/en not_active Ceased
- 1999-01-04 AT AT99900369T patent/ATE237349T1/de not_active IP Right Cessation
- 1999-01-04 EP EP99900369A patent/EP1043981B1/en not_active Expired - Lifetime
- 1999-01-04 NZ NZ523301A patent/NZ523301A/en unknown
-
2000
- 2000-07-06 MX MXPA00006681 patent/MX222446B/es active IP Right Grant
- 2000-07-07 NO NO20003510A patent/NO20003510L/no not_active Application Discontinuation
-
2002
- 2002-02-01 AU AU2002014755A patent/AU2002014755A1/xx not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1043981A2 (en) | 2000-10-18 |
| HK1034044A1 (en) | 2001-10-12 |
| KR100773625B1 (ko) | 2007-11-05 |
| DE69906928D1 (de) | 2003-05-22 |
| AU1950599A (en) | 1999-07-26 |
| KR20010034013A (ko) | 2001-04-25 |
| MX222446B (en) | 2004-09-01 |
| ES2200493T3 (es) | 2004-03-01 |
| PL193452B1 (pl) | 2007-02-28 |
| MXPA00006681A (es) | 2001-02-01 |
| CN1288381A (zh) | 2001-03-21 |
| CN1212123C (zh) | 2005-07-27 |
| NO20003510L (no) | 2000-09-07 |
| NZ505294A (en) | 2003-02-28 |
| KR20060111741A (ko) | 2006-10-27 |
| NO20003510D0 (no) | 2000-07-07 |
| AU2002014755A1 (en) | 2002-03-14 |
| HUP0100890A3 (en) | 2001-12-28 |
| IL137096A (en) | 2006-10-31 |
| HUP0100890A2 (hu) | 2001-08-28 |
| RU2222335C2 (ru) | 2004-01-27 |
| ATE237349T1 (en) | 2003-05-15 |
| CA2318417A1 (en) | 1999-07-15 |
| IL137096A0 (en) | 2001-06-14 |
| JP2002500183A (ja) | 2002-01-08 |
| PL343898A1 (en) | 2001-09-10 |
| DE69906928T2 (de) | 2004-02-19 |
| AU740233B2 (en) | 2001-11-01 |
| NZ523301A (en) | 2005-11-25 |
| EP1043981B1 (en) | 2003-04-16 |
| WO1999034787A3 (en) | 2000-01-20 |
| WO1999034787A2 (en) | 1999-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9911071A (pt) | Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido | |
| BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
| BR0009647A (pt) | Docetaxel em combinação com rhumab her2 para o tratamento de cânceres | |
| BR9812484A (pt) | Terapia combinada para erradicação de hcv-rna detectável em pacientes com infecção crÈnica por hepatite c | |
| KR950002785A (ko) | 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜 | |
| EP1736152A3 (en) | Physiologically stable compositions of butyric acid as well as butyric acid salts and derivatives for treating wounds | |
| BR9911076A (pt) | Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica | |
| BR0112685A (pt) | Composição nutricional | |
| BR0113447A (pt) | Método de tratamento ou prevenção do câncer em um ser humano, e, composição farmacêutica | |
| BR9807673A (pt) | Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica. | |
| BR0109336A (pt) | Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico | |
| BR0212078A (pt) | Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto | |
| BR9908030A (pt) | Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado | |
| US20030069171A1 (en) | Nutritional composition for the treatment of connective tissue | |
| BR0212907A (pt) | Métodos para tratamento ou prevenção de inflamação vascular usando inibidor(es) da absorção de esteróis | |
| BR0111591A (pt) | Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes | |
| BR0213100A (pt) | Combinações para o tratamento de distúrbios imuniinflamatórios | |
| BR9709838A (pt) | Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase | |
| ATE99172T1 (de) | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. | |
| BRPI0410131A (pt) | suplemento dietético para uso no tratamento e/ou inibição de úlceras do trato digestivo em equinos e outros animais e seu método | |
| BR0214075A (pt) | Dosagem unitária que compreende um análogo de prostaglandina para tratar constipação | |
| BR0111506A (pt) | Complexos de droga macromoleculares e composições contendo os mesmos | |
| BR9809694A (pt) | Processo e composição para administração de taxanos oralmente a pacientes humanos | |
| BR0015149A (pt) | Método e composições para administração de taxanos oralmente a pacientes humanos | |
| WO2001005408A8 (en) | Fat-binding polymers, optionally combined with lipase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: GENZYME CORPORATION (US) Free format text: TRANSFERIDO POR INCORPORACAO DE: GELTEX PHARMACEUTICALS, INC. |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/00 (2008.04) |
|
| B25G | Requested change of headquarter approved |
Owner name: GENZYME CORPORATION (US) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018080029522/SP DE 14/05/2008. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM ART. 8O, 11, 13, E 25 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |